Erika Brunet works on cancer biology to understand how DNA alterations induce the appearance of cancers. Using genome editing methods like CRISPR/Cas9, she deciphers how normal cells become cancerous in order to identify new therapeutic targets. She works as research director at the INSERM, in the Genome Dynamics in the Immune System lab at the Imagine Institute, Paris.
